|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2011-8-22
|
|
pubmed:abstractText |
Melanoma has a high potential to develop metastases. Accurate staging is essential for appropriate management. Sentinel node (SN) status is a powerful prognostic factor in early stage melanoma. Staging is assisted by SN biopsy after lymphoscintigraphy to locate all true SNs prior to biopsy. PET using F18-FDG can detect metastases and is used to restage patients with AJCC Stages III and IV disease before planning surgery with curative intent.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1096-9098
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright © 2011 Wiley-Liss, Inc.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
104
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
405-19
|
|
pubmed:meshHeading |
pubmed-meshheading:21858836-Fluorodeoxyglucose F18,
pubmed-meshheading:21858836-Humans,
pubmed-meshheading:21858836-Lymph Nodes,
pubmed-meshheading:21858836-Melanoma,
pubmed-meshheading:21858836-Neoplasm Staging,
pubmed-meshheading:21858836-Positron-Emission Tomography,
pubmed-meshheading:21858836-Practice Guidelines as Topic,
pubmed-meshheading:21858836-Radiometry,
pubmed-meshheading:21858836-Radiopharmaceuticals,
pubmed-meshheading:21858836-Sentinel Lymph Node Biopsy,
pubmed-meshheading:21858836-Skin,
pubmed-meshheading:21858836-Skin Neoplasms
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Guidelines for lymphoscintigraphy and F18 FDG PET scans in melanoma.
|
|
pubmed:affiliation |
Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. ruren@usyd.edu.au
|
|
pubmed:publicationType |
Journal Article
|
